DMI segments the Artificial Heart-Lung Machine Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.
An artificial heart-lung machine is used in open-heart surgery to support the proper functioning of the heart and body during the surgery. The heart-lung machine contains a chamber that receives the blood from the body, oxygenates and transfers the blood to all parts of the body. The machine is connected to the patient with a series of tubes, which is then removed after the completion of the surgery when the heart and lungs resume its normal functions. The global artificial heart-lung machine market is expected to grow at a significant rate owing to the increasing number of cardiovascular surgeries and the presence of technological advancements in the field. Also, growing awareness in the field and the presence of government initiatives in improving the healthcare facilities are helping in increasing the global market for the artificial heart-lung machine market.
Rising Heart Disease Prevalence and Growing geriatric population Fuel Market
According to the WHO, around 17.9 million people die of cardiovascular diseases, every year, an estimated 31% of all the deaths worldwide. Four out of five CVD deaths are due to heart attacks and strokes. According to the World Journal of Cardiovascular Diseases, more than 7 million deaths are due to the sudden cardiac arrest across the world each year. Thus, the growing number of heart failures, strokes, heart attacks, and other heart-related illness are driving the market growth.
The rising geriatric population is expected to boost the market. Many nations are facing challenges due to the ongoing and the increasing demographic shift in age among their people. As per the Department of Economic and Social Affairs Population Division of UN, 2017, the world's population of 60 years will double and those of 80 years old will triple in the next 30 years. As per WHO, the number of people of age 65 or older is expected to grow to around 1.5 billion in 2050, with most of the increase in the developing countries. Thus, the growing geriatric population, who are more prone to chronic illness like CVDs, are driving the market.
Shortage of skilled professionals and Stringent Regulations to Hinder Market Progress
Shortage of skilled professionals and stringent government regulations are the major market restraining factors. The shortage of skilled surgeons to perform cardiac surgeries is likely to restrain the market. For instance, according to a news published in Science Daily on May 17, 2016, the American Association for Thoracic Surgery has estimated that looking forward to 2035, a growing imbalance is projected between the number of cardiothoracic surgeons required and the number available. Also, they have estimated that cardiothoracic surgeons should increase their caseload by 121 % to meet the demand of rising incidences of cardiovascular disease.
Cardiac Surgery Anticipated to Gain Notable Traction
By application, cardiac surgery is likely to grow at a rapid CAGR in the forecast period. The increasing number of cardiac surgeries is expected to propel market growth. For instance, according to the Texas Heart Institute, thousands of heart surgeries are performed every day in the US. Even though there is a shortage of donor organs, more than 3,400 people have heart transplants every year. Thus, the increasing number of cardiac surgeries are driving the market growth.
North-America Artificial Heart-Lung Machine Market to Expand Robustly
DMI segments the global artificial heart-lung machine market into – North America, South America, Europe, Asia-Pacific (APAC), and the Middle East and Africa.
North America is dominating the global artificial heart-lung machine market in 2018 and is estimated to hold significant market size over the forecast period (2019-2026) owing to the increasing incidences of cardiovascular diseases, rapid technological advances, increasing awareness among the population, and the growing preference for minimally invasive procedures.
The rising incidences of cardiovascular diseases are expected to drive the market over the forecast period. For instance, according to the American College of Cardiology, cardiovascular disease accounted for 800,000 deaths in the US in 2017 alone. Also, among Americans, an average of one person dies from cardiovascular disease, every 40 seconds. Coronary heart disease accounts for the majority of CVD deaths, followed by stroke and heart failure. CDC has estimated that the heart disease is the leading causing of death in the US, and responsible for 1 in 4 deaths every year. Almost 6 million Americans currently have heart failure, a figure which is expected to increase by 46 %, to 8 million, by 2030. Thus, the growing number of cardiovascular diseases is driving the market.
Highly Concentrated Competitive Market with Few Major Contributors
The global artificial heart-lung machine market is highly competitive. Key market players include – Sorin Group, LivaNova Plc, Gettinge group, Terumo Corporation, SynCardia, Medtronic, and MAQUET GmbH & Co. KG.
Key players are highly investing in R&D for the advent of first-in-class drug types to sustain and improve market competitiveness. Few competitors are also adopting inorganic growth strategies such as mergers & acquisitions to diversify product portfolio and enhance geographic footprint.
Artificial Heart-Lung Machine Market Taxonomy:
Get free insights Report on Artificial Heart-Lung Machine Market
About: DataM Intelligence
DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision making in designing disruptive solutions. This aids us in providing the detail scenario of the present and future of the market.
For more insights, please visit, https://www.datamintelligence.com/
Tags: #artificialheartlungmachinemarket, #artificialheartlungmachinesize, #artificialheartlungmachineshare, #artificialheartlungmachineforecast, #artificialheartlungmachinetrends, #artificialheartlungmachinegrowth